Inflammation

Dr David Pariser Outlines Future Treatment Options of Atopic Dermatitis With Biologics and JAK Inhibitors

November 28th 2020, 1:45pm

Video

As the only biologic on the market, dupilumab has replaced most of the more traditional treatments for atopic dermatitis, said David Pariser, MD, senior physician at Pariser Dermatology Specialists.

Behavior Intervention Can Increase Physical Activity and Improve Asthma Control

November 25th 2020, 2:45pm

Article

Patients with asthma can improve their disease control and sleep quality, while reducing depression and anxiety through a behavior change intervention aimed at increasing their physical activity.

Insurance Expansion Reduced Asthma Emergencies in New York City

November 17th 2020, 2:15pm

Article

Expansion of insurance coverage due to the Affordable Care Act led to a reduction in the use of emergency services for patients with asthma in New York City.

Dupilumab Reduces Pain, Discomfort in Patients With Moderate to Severe Atopic Dermatitis

November 15th 2020, 2:30pm

Article

Dupilumab, with or without topical corticosteroids, significantly reduced pain and discomfort in patients with moderate to severe atopic dermatitis.

Dr Nicola Hanania: Treatment of T2-High Asthma Is Constantly Evolving

November 11th 2020, 3:00pm

Video

Treatment targets include several interleukins, immunoglobulin E, and alarmins, pointed out Nicola Hanania, MD, MS, pulmonary critical care physician and director, Airway Clinical Research Center, Baylor College of Medicine, Houston.

Overuse of Reliever Inhalers Does Not Necessarily Mean Greater Health Care Utilization

November 8th 2020, 4:00pm

Article

Overuse of reliever inhalers among adult patients with asthma is prevalent, but does not necessarily translate into higher all-cause health care utilization (HCU), according to a study published in Scientific Reports.

Dr Anne Reihman: Anti–IL-5 Therapies Can Be Life-Changing for Patients With Eosinophilic Asthma

November 7th 2020, 3:30pm

Video

Categorizing by eosinophilic/noneosinophilic subtype enables better targeted treatment, noted Anne Reihman, MD, third-year pulmonary and critical care fellow, University of Colorado, Division of Pulmonary Sciences and Critical Care Medicine.

Vitamin D May Ease Symptoms of Severe Atopic Dermatitis in Children

November 6th 2020, 2:30pm

Article

Vitamin D used as an adjuvant therapy in children with severe atopic dermatitis may improve clinical outcomes, according to a recent study.

Dr J. Allen Meadows Discusses Adherence to Biologics for Asthma

October 31st 2020, 12:30pm

Video

Despite the price, adherence to biologics for asthma is usually good because of the effectiveness, said J. Allen Meadows, MD, president of the American College of Allergy, Asthma & Immunology.

Weighing the Pros, Cons of At-Home Use of Biologics for Asthma

October 28th 2020, 7:30pm

Article

When the first biologic to treat asthma was approved by the FDA in 2003, it needed to be administered subcutaneously in the physician’s office. Now, there are 3 options available for at-home use: mepolizumab, benralizumab, and dupilumab.